共 12 条
Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial
被引:22
|作者:
Spies, Claudia
[1
,2
]
Luetz, Alawi
[1
,2
]
Lachmann, Gunnar
[1
,2
]
Renius, Markus
[1
,2
]
von Haefen, Clarissa
[1
,2
]
Wernecke, Klaus-Dieter
[3
]
Bahra, Marcus
[4
]
Schiemann, Alexander
[1
,2
]
Paupers, Marco
[1
,2
]
Meisel, Christian
[5
]
机构:
[1] Charite, Campus Charite Mitte, Dept Anesthesiol & Intens Care Med, D-13353 Berlin, Germany
[2] Charite, Campus Virchow Klinikum, D-13353 Berlin, Germany
[3] Sostana GmbH, Berlin, Germany
[4] Charite, Dept Gen Abdominal & Transplantat Surg, Campus Virchow Klinikum, D-13353 Berlin, Germany
[5] Charite, Inst Med Immunol, Campus Virchow Klinikum, D-13353 Berlin, Germany
来源:
PLOS ONE
|
2015年
/
10卷
/
12期
关键词:
FACTOR GM-CSF;
INTENSIVE-CARE;
SYSTEMIC INFLAMMATION;
3;
SCORES;
EXPRESSION;
MORTALITY;
VACCINES;
SEPSIS;
SAFETY;
PATHOPHYSIOLOGY;
D O I:
10.1371/journal.pone.0144003
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Purpose Surgical patients are at high risk for developing infectious complications and postoperative delirium. Prolonged infections and delirium result in worse outcome. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and influenza vaccination are known to increase HLA-DR on monocytes and improve immune reactivity. This study aimed to investigate whether GM-CSF or vaccination reverses monocyte deactivation. Secondary aims were whether it decreases infection and delirium days after esophageal or pancreatic resection over time. Methods In this prospective, randomized, placebo-controlled, double-blind, double dummy trial setting on an interdisciplinary ICU of a university hospital 61 patients with immunosuppression (monocytic HLA-DR [mHLA-DR] < 10,000 monoclonal antibodies [mAb] per cell) on the first day after esophageal or pancreatic resection were treated with either GM-CSF (250 mu g/m2/d), influenza vaccination (Mutagrip 0.5 ml/d) or placebo for a maximum of 3 consecutive days if mHLA-DR remained below 10,000 mAb per cell. HLA-DR on monocytes was measured daily until day 5 after surgery. Infections and delirium were followed up for 9 days after surgery. Primary outcome was HLA-DR on monocytes, and secondary outcomes were duration of infection and delirium. Results mHLA-DR was significantly increased compared to placebo (p < 0.001) and influenza vaccination (p < 0.001) on the second postoperative day. Compared with placebo, GM-CSF-treated patients revealed shorter duration of infection (p < 0.001); the duration of delirium was increased after vaccination (p = 0.003). Conclusion Treatment with GM-CSF in patients with postoperative immune suppression was safe and effective in restoring monocytic immune competence. Furthermore, therapy with GM-CSF reduced duration of infection in immune compromised patients. However, influenza vaccination increased duration of delirium after major surgery.
引用
收藏
页数:15
相关论文